Zacks.com on MSN
Why Merck's 32% Rally Isn't Enough to Change the Bearish View
MRK is up over 32% in three months, but declining estimates, Keytruda's upcoming LOE and Gardasil declines keep the stock ...
Quickly compare all the best investment platforms. Find the investment platforms that offer the most security, lowest fees, and best offers.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈